112 related articles for article (PubMed ID: 25790738)
21. Prediction of major bleeding events in 1381 patients with essential thrombocythemia.
Stuckey R; Ianotto JC; Santoro M; Czyż A; Encinas MMP; Gómez-Casares MT; Pereira MSN; de Nałęcz AK; Gołos A; Lewandowski K; Szukalski Ł; González-Martín JM; Sobas MA
Int J Hematol; 2023 Nov; 118(5):589-595. PubMed ID: 37660316
[TBL] [Abstract][Full Text] [Related]
22. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
[TBL] [Abstract][Full Text] [Related]
23. Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia.
Alvarez-Larrán A; Cuevas B; Velez P; Noya S; Caballero-Navarro G; Ferrer-Marín F; Carbonell S; Pérez-Encinas M; Gómez-Casares MT; Pérez-López R; Magro E; Moretó A; Pastor-Galán I; Angona A; Mata-Vázquez MI; Guerrero-Fernández L; Guerra JM; Carreño-Tarragona G; Fox L; Murillo I; García-Gutiérrez V; Mora E; Stuckey R; Arellano-Rodrigo E; Hernández-Boluda JC; Pereira A
Hemasphere; 2023 Aug; 7(8):e936. PubMed ID: 37476303
[TBL] [Abstract][Full Text] [Related]
24. Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.
Palandri F; Polverelli N; Catani L; Ottaviani E; Baccarani M; Vianelli N
Ann Hematol; 2011 Aug; 90(8):933-8. PubMed ID: 21287350
[TBL] [Abstract][Full Text] [Related]
25. Developments in diagnosis and treatment of essential thrombocythemia.
Mora B; Passamonti F
Expert Rev Hematol; 2019 Mar; 12(3):159-171. PubMed ID: 30793984
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of bone marrow biopsy in essential thrombocythemia.
Annaloro C; Lambertenghi Deliliers G; Oriani A; Pozzoli E; Lambertenghi Deliliers D; Radaelli F; Faccini P
Haematologica; 1999 Jan; 84(1):17-21. PubMed ID: 10091388
[TBL] [Abstract][Full Text] [Related]
27. Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia.
Finazzi G; Carobbio A; Guglielmelli P; Cavalloni C; Salmoiraghi S; Vannucchi AM; Cazzola M; Passamonti F; Rambaldi A; Barbui T
Blood; 2014 Oct; 124(16):2611-2. PubMed ID: 25323688
[No Abstract] [Full Text] [Related]
28. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
[TBL] [Abstract][Full Text] [Related]
29. Contribution of cardiovascular risk factors in the thrombotic complications of essential thrombocythaemia: a Hungarian single-institute retrospective analysis.
Pósfai É; Marton I; Kotosz B; Borbényi Z
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1258-63. PubMed ID: 25912587
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.
Passamonti F; Rumi E; Arcaini L; Boveri E; Elena C; Pietra D; Boggi S; Astori C; Bernasconi P; Varettoni M; Brusamolino E; Pascutto C; Lazzarino M
Haematologica; 2008 Nov; 93(11):1645-51. PubMed ID: 18790799
[TBL] [Abstract][Full Text] [Related]
31. What factors determine the pregnancy outcome in patients with essential thrombocythemia?
Kwiatkowski J; Kuliszkiewicz-Janus M; Potoczek S; Jaźwiec B; Wróbel T; Małecki R
J Matern Fetal Neonatal Med; 2022 Dec; 35(24):4734-4738. PubMed ID: 33792458
[No Abstract] [Full Text] [Related]
32. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).
Barbui T; Finazzi G; Carobbio A; Thiele J; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Randi ML; Bertozzi I; Gisslinger H; Buxhofer-Ausch V; De Stefano V; Betti S; Rambaldi A; Vannucchi AM; Tefferi A
Blood; 2012 Dec; 120(26):5128-33; quiz 5252. PubMed ID: 23033268
[TBL] [Abstract][Full Text] [Related]
33. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
34. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.
Wolanskyj AP; Schwager SM; McClure RF; Larson DR; Tefferi A
Mayo Clin Proc; 2006 Feb; 81(2):159-66. PubMed ID: 16471068
[TBL] [Abstract][Full Text] [Related]
35. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
[TBL] [Abstract][Full Text] [Related]
36. Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients.
Montanaro M; Latagliata R; Cedrone M; Spadea A; Rago A; Di Giandomenico J; Spirito F; Porrini R; De Muro M; Leonetti SC; Villivà N; De Gregoris C; Breccia M; Montefusco E; Santoro C; Cimino G; Majolino I; Mazzucconi MG; Alimena G; Andriani A
Am J Hematol; 2014 May; 89(5):542-6. PubMed ID: 24481665
[TBL] [Abstract][Full Text] [Related]
37. Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.
Piccin A; Steurer M; Mitterer M; Blöchl EM; Marcheselli L; Pusceddu I; Marabese A; Bertozzi I; Corvetta D; Randi ML; Elli E; Pogliani EM; Veneri D; Perbellini O; Krampera M; Pacquola E; Gottardi M; Tiribelli M; Guella A; Innella B; Vivaldi P; De Biasi E; Sancetta R; Rocconi R; Bassan R; Gherlinzoni F; Pizzolo G; Gastl G; Cortelazzo S
Intern Emerg Med; 2015 Jun; 10(4):451-60. PubMed ID: 25585678
[TBL] [Abstract][Full Text] [Related]
38. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
Gangat N; Wolanskyj AP; Schwager SM; Hanson CA; Tefferi A
Cancer; 2009 Dec; 115(24):5740-5. PubMed ID: 19806641
[TBL] [Abstract][Full Text] [Related]
39. The predictive value of megakaryocytic and erythroid colony formation and platelet function tests on the risk of thromboembolic and bleeding complications in essential thrombocythaemia.
Niittyvuopio R; Juvonen E; Kekomäki R; Oksanen K; Anttila P; Ruutu T
Eur J Haematol; 2004 Apr; 72(4):245-51. PubMed ID: 15089761
[TBL] [Abstract][Full Text] [Related]
40. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
